This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Sep 1;297(9):484-91.

doi: 10.1056/NEJM197709012970907.

Immunotherapy of cancer

PMID: 301988
DOI: 10.1056/NEJM197709012970907

Immunotherapy of cancer

H F Oettgen. N Engl J Med. 1977.

. 1977 Sep 1;297(9):484-91.

doi: 10.1056/NEJM197709012970907.

Author

PMID: 301988
DOI: 10.1056/NEJM197709012970907

No abstract available

PubMed Disclaimer

Similar articles

Current aspects of tumor immunology. Preface and introduction.
Weiss DW. Weiss DW. Isr J Med Sci. 1973 Mar;9(3):205-16. Isr J Med Sci. 1973. PMID: 4575649 Review. No abstract available.
An insight into cancer immunology and immunotherapy.
Thompson RB. Thompson RB. Prog Clin Pathol. 1975;6:159-76. Prog Clin Pathol. 1975. PMID: 1105670 Review. No abstract available.
Cancer immunotherapy: an overview.
Morton DL. Morton DL. Semin Oncol. 1974 Dec;1(4):297-310. Semin Oncol. 1974. PMID: 4620437 Review. No abstract available.
The immunology of tumors.
Burk MW, Mckhann CF. Burk MW, et al. Surg Annu. 1973;5:1-29. Surg Annu. 1973. PMID: 4602210 Review. No abstract available.
The immunology of cancer.
Angel Basombrío M. Angel Basombrío M. J Oral Pathol. 1973;2(5):231-53. J Oral Pathol. 1973. PMID: 4207800 Review. No abstract available.

See all similar articles

Cited by

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells.
Calmeiro J, Carrascal MA, Tavares AR, Ferreira DA, Gomes C, Falcão A, Cruz MT, Neves BM. Calmeiro J, et al. Pharmaceutics. 2020 Feb 15;12(2):158. doi: 10.3390/pharmaceutics12020158. Pharmaceutics. 2020. PMID: 32075343 Free PMC article. Review.
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
Roncati L, Vadalà M, Corazzari V, Palmieri B. Roncati L, et al. Vaccine. 2020 Nov 10;38(48):7581-7584. doi: 10.1016/j.vaccine.2020.10.013. Epub 2020 Oct 9. Vaccine. 2020. PMID: 33071005 Free PMC article.
Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy.
Calmeiro J, Carrascal M, Gomes C, Falcão A, Cruz MT, Neves BM. Calmeiro J, et al. J Immunother Cancer. 2019 Sep 4;7(1):238. doi: 10.1186/s40425-019-0716-8. J Immunother Cancer. 2019. PMID: 31484548 Free PMC article. Review.
Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.
O'Neill GJ, Stebbing N. O'Neill GJ, et al. Br J Cancer. 1980 Feb;41(2):243-9. doi: 10.1038/bjc.1980.36. Br J Cancer. 1980. PMID: 7370164 Free PMC article.
Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.
Zier KS, Huber C, Albert E, Braunsteiner H. Zier KS, et al. Clin Exp Immunol. 1980 Apr;40(1):136-46. Clin Exp Immunol. 1980. PMID: 6446429 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.